Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
JMJD4 pseudogene 1 (JMJD4P1) is a genomic sequence related to the protein-coding JMJD4 gene, but it is classified as a pseudogene and does not encode a functional protein. Pseudogenes like JMJD4P1 generally arise from gene duplication or retrotransposition events, after which they acquire disabling mutations. JMJD4P1 is not a recognized therapeutic target, and there is no known molecular function, disease involvement, or drug interaction information applicable to it. Research and clinical interest focus on JMJD4, a protein-coding gene implicated in protein hydroxylation and being explored as a cancer marker, not JMJD4P1[2][3]. If you meant the canonical, functional JMJD4 gene (“Jumonji domain containing 4”), please clarify, as the pseudogene is not a therapeutic target and is not involved in cancer or other disease mechanisms[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Jumonji domain containing 4 pseudogene 1 (JMJD4P1).